|
DE3127503A1
(de)
*
|
1981-07-11 |
1983-02-17 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
|
IL63734A
(en)
*
|
1981-09-04 |
1985-07-31 |
Yeda Res & Dev |
Lipid fraction,its preparation and pharmaceutical compositions containing same
|
|
US4578391A
(en)
*
|
1982-01-20 |
1986-03-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
Oily compositions of antitumor drugs
|
|
US4452747A
(en)
*
|
1982-03-22 |
1984-06-05 |
Klaus Gersonde |
Method of and arrangement for producing lipid vesicles
|
|
US5334583A
(en)
*
|
1982-07-23 |
1994-08-02 |
Ciba-Geigy Corp. |
Use of sugar derivatives for the prophylaxis and treatment of virus infections
|
|
US5189017A
(en)
*
|
1982-07-23 |
1993-02-23 |
Ciba-Geigy Corporation |
Use of sugar derivatives for the prophylaxis and treatment of virus infections
|
|
CA1237670A
(en)
*
|
1983-05-26 |
1988-06-07 |
Andrew S. Janoff |
Drug preparations of reduced toxicity
|
|
US5059591B1
(en)
*
|
1983-05-26 |
2000-04-25 |
Liposome Co Inc |
Drug preparations of reduced toxicity
|
|
US4649155A
(en)
*
|
1983-07-22 |
1987-03-10 |
Hoffmann-La Roche Inc. |
Injectable solutions
|
|
JPS6045518A
(ja)
*
|
1983-08-22 |
1985-03-12 |
Takeda Chem Ind Ltd |
抗シヨツク剤
|
|
US4873088A
(en)
*
|
1983-09-06 |
1989-10-10 |
Liposome Technology, Inc. |
Liposome drug delivery method and composition
|
|
JPS6081193A
(ja)
*
|
1983-10-11 |
1985-05-09 |
Takeda Chem Ind Ltd |
リン脂質
|
|
JPS60208910A
(ja)
*
|
1984-03-31 |
1985-10-21 |
Green Cross Corp:The |
水難溶性薬物・リン脂質複合体の製造方法
|
|
PT78628B
(en)
*
|
1984-05-02 |
1986-06-18 |
Liposome Co Inc |
Pharmaceutical composition with reduced toxicity
|
|
DE3421468A1
(de)
*
|
1984-06-08 |
1985-12-19 |
Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim |
Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
|
|
ATE45744T1
(de)
*
|
1984-07-25 |
1989-09-15 |
Ciba Geigy Ag |
Phosphatidylverbindungen, verfahren zu ihrer herstellung und ihre verwendung.
|
|
US5077056A
(en)
*
|
1984-08-08 |
1991-12-31 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
US5736155A
(en)
*
|
1984-08-08 |
1998-04-07 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
US4921706A
(en)
*
|
1984-11-20 |
1990-05-01 |
Massachusetts Institute Of Technology |
Unilamellar lipid vesicles and method for their formation
|
|
US4622188A
(en)
*
|
1984-12-21 |
1986-11-11 |
E. I. Du Pont De Nemours And Company |
Method for manufacturing liposomes
|
|
US4737276A
(en)
*
|
1984-12-21 |
1988-04-12 |
E. I. Du Pont De Nemours And Company |
Apparatus for manufacturing liposomes
|
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
|
US4916249A
(en)
*
|
1985-07-03 |
1990-04-10 |
Hans Brachwitz |
Glycero-3(2)-phospho-L-serine derivatives and salts thereof
|
|
US4857514A
(en)
*
|
1985-09-17 |
1989-08-15 |
Yeda Research And Development Company, Ltd. |
Virus inactivation
|
|
WO1987002253A1
(en)
*
|
1985-10-21 |
1987-04-23 |
The Liposome Company, Inc. |
In situ preparation and delivery of liposomes
|
|
US4923854A
(en)
*
|
1986-01-22 |
1990-05-08 |
The Liposome Company, Inc. |
Solubilization of hydrophobic materials using lysophospholipid
|
|
US4873322A
(en)
*
|
1986-01-24 |
1989-10-10 |
Ciba-Geigy Corporation |
Saccharide derivatives and processes for their manufacture
|
|
US4737323A
(en)
*
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
US4971801A
(en)
*
|
1986-06-09 |
1990-11-20 |
Cell Technology, Inc. |
Biologic response modifier
|
|
US5009956A
(en)
*
|
1987-02-24 |
1991-04-23 |
Univ Minnesota |
Phospholipase A2-resistant liposomes
|
|
US5616334A
(en)
*
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
|
US6406713B1
(en)
|
1987-03-05 |
2002-06-18 |
The Liposome Company, Inc. |
Methods of preparing low-toxicity drug-lipid complexes
|
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
|
EP0414663A4
(en)
*
|
1987-04-16 |
1991-07-17 |
The Liposome Company, Inc. |
Liposome continuous size reduction method and apparatus
|
|
US5030733A
(en)
*
|
1987-07-23 |
1991-07-09 |
Hoechst-Roussel Pharmaceticals Incorporated |
Hydroxy-, alkoxy- and benzyloxy-substituted phospholipids
|
|
US5145844A
(en)
*
|
1987-07-23 |
1992-09-08 |
Hoechst-Roussel Pharmaceuticals Incorporated |
Methods of using hydroxy-, alkoxy- and benzyloxy-substituted phospholipids to treat phospholipase A2 -mediated conditions and to alleviate pain
|
|
US4978332A
(en)
*
|
1987-09-28 |
1990-12-18 |
Matrix Pharmaceutical, Inc. |
Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas
|
|
US5185334A
(en)
*
|
1989-07-31 |
1993-02-09 |
Schering Corporation |
2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use
|
|
US5036152A
(en)
*
|
1988-03-10 |
1991-07-30 |
Hoechst-Roussel Pharmaceuticals Incorporated |
Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
|
|
US4888328A
(en)
*
|
1988-03-10 |
1989-12-19 |
Hoeschst-Roussel Incorporated |
Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
|
|
US5230900A
(en)
*
|
1988-07-01 |
1993-07-27 |
The Biomembrane Institute |
Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells
|
|
ES2053925T3
(es)
*
|
1988-11-23 |
1994-08-01 |
Abbott Lab |
Una composicion para el tratamiento de pacientes con sindrome de inmunodeficiencia adquirida.
|
|
DE3906952A1
(de)
*
|
1989-03-04 |
1990-09-06 |
Boehringer Mannheim Gmbh |
(3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
|
|
US5100662A
(en)
*
|
1989-08-23 |
1992-03-31 |
The Liposome Company, Inc. |
Steroidal liposomes exhibiting enhanced stability
|
|
WO1992002244A1
(en)
*
|
1990-07-31 |
1992-02-20 |
The Liposome Company, Inc. |
Accumulation of amino acids and peptides into liposomes
|
|
WO1992008448A1
(en)
*
|
1990-11-09 |
1992-05-29 |
Cell Technology, Inc. |
Method for preventing drug-induced or radiation myelosuppression
|
|
US5620703A
(en)
*
|
1991-10-11 |
1997-04-15 |
Max-Delbruck-Centrum Fur Molekulare Medizin |
Stimulating hematopoietic activity with carboplatin or lobaplatin
|
|
US5817646A
(en)
*
|
1991-11-15 |
1998-10-06 |
Laboratoires Inocosm |
Polar lipid composition of plant origin
|
|
IT1255476B
(it)
*
|
1992-07-30 |
1995-11-02 |
|
Glicerofosfoderivati farmacologicamente attivi
|
|
CN1132586C
(zh)
|
1993-09-09 |
2003-12-31 |
罗拉斯医疗公司 |
来自胆汁的免疫调节组合物、其制备方法及其用途
|
|
US6551623B1
(en)
|
1993-09-09 |
2003-04-22 |
Lorus Therapeutics Inc. |
Immunomodulating compositions from bile
|
|
US5707978A
(en)
*
|
1994-11-22 |
1998-01-13 |
Clarion Pharmaceuticals Inc. |
Heteroaryl-substituted deoxy glycero-phosphoethanolamines
|
|
AU711294B2
(en)
|
1995-03-16 |
1999-10-07 |
Erin Mills Biotech Inc. |
Immunomodulating compositions from bile for the treatment of immune system disorders
|
|
US5834428A
(en)
*
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
US6184201B1
(en)
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
|
US5990077A
(en)
|
1995-04-14 |
1999-11-23 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
US5703062A
(en)
*
|
1995-12-07 |
1997-12-30 |
Clarion Pharmaceuticals Inc. |
N-het-substituted glycerophosphoethanolamines
|
|
US5665714A
(en)
*
|
1995-12-07 |
1997-09-09 |
Clarion Pharmaceuticals Inc. |
N-substituted glycerophosphoethanolamines
|
|
US5730157A
(en)
*
|
1995-12-07 |
1998-03-24 |
Clarion Pharmaceuticals Inc. |
Method for treating viral infection
|
|
ES2351661T3
(es)
|
1996-04-12 |
2011-02-09 |
1149336 Ontario Inc. |
Péptido-2 análogo al glucagón.
|
|
US20040101569A1
(en)
*
|
1996-05-16 |
2004-05-27 |
Lorus Therapeutics Inc. |
Immunomodulating compositions from bile
|
|
US6111081A
(en)
*
|
1996-05-31 |
2000-08-29 |
Baylor College Of Medicine |
Lactoferrin variants and uses thereof
|
|
US5932242A
(en)
*
|
1996-10-15 |
1999-08-03 |
The Liposome Company, Inc. |
Ether lipid-containing pharmaceutical compositions and therapeutic uses thereof
|
|
US6037125A
(en)
*
|
1996-11-05 |
2000-03-14 |
Lexicon Genetics Incorporated |
Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
|
|
US5827836A
(en)
*
|
1996-11-15 |
1998-10-27 |
Clarion Pharmaceuticals Inc. |
Retinoid glycerol phospholipid conjugates
|
|
CA2236519C
(en)
*
|
1997-05-02 |
2011-09-13 |
1149336 Ontario Inc. |
Methods of enhancing functioning of the large intestine
|
|
GB9906695D0
(en)
*
|
1999-03-24 |
1999-05-19 |
Secr Defence |
Vaccine composition
|
|
US20020001614A1
(en)
*
|
2000-02-10 |
2002-01-03 |
Kent Jorgensen |
Lipid-based drug delivery systems containing phospholipase A2 degradable lipid derivatives and the therapeutic uses thereof
|
|
WO2003075889A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
|
WO2006039807A1
(en)
*
|
2004-10-15 |
2006-04-20 |
Biopharmacopae Design International Inc. |
Methods and therapeutic compositions comprising plant extracts for the treatment of cancer
|
|
MXPA05004580A
(es)
*
|
2002-10-29 |
2005-07-26 |
Transave Inc |
Liberacion sostenida de anti - infecciosos.
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
US20060078560A1
(en)
*
|
2003-06-23 |
2006-04-13 |
Neopharm, Inc. |
Method of inducing apoptosis and inhibiting cardiolipin synthesis
|
|
EP1745788A1
(de)
*
|
2005-07-22 |
2007-01-24 |
KTB Tumorforschungsgesellschaft mbH |
Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
|
|
HUE029994T2
(en)
|
2005-12-08 |
2017-04-28 |
Insmed Inc |
Lipid-based preparations of antinfectants for the treatment of lung infections
|
|
WO2008137717A1
(en)
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
CN101358609A
(zh)
*
|
2007-08-03 |
2009-02-04 |
富准精密工业(深圳)有限公司 |
风扇转子
|
|
US9168288B2
(en)
|
2010-04-09 |
2015-10-27 |
Mount Sinai Hospital |
Methods for treating disorders of the gastrointestinal tract using a GLP-1 agonist
|
|
PT2852391T
(pt)
|
2012-05-21 |
2022-02-18 |
Insmed Inc |
Sistemas para tratamento de infeções pulmonares
|
|
AU2013352259B2
(en)
|
2012-11-29 |
2018-06-14 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
|
KR101951933B1
(ko)
*
|
2013-03-12 |
2019-02-25 |
주식회사 아리바이오 |
라이소포스파티딜콜린 또는 이의 유도체를 포함하는 지질나노물질 및 이의 제조방법
|
|
EP4219534A3
(en)
|
2013-07-08 |
2023-09-27 |
The University of Utah Research Foundation |
Methods for treatment of and prophylaxis against inflammatory disorders
|
|
JP6139781B2
(ja)
*
|
2014-04-04 |
2017-05-31 |
国立大学法人大阪大学 |
リゾリン脂質受容体を活性化する物質を含有する薬剤送達促進剤
|
|
RS60827B1
(sr)
|
2014-05-15 |
2020-10-30 |
Insmed Inc |
Postupci lečenja plućnih netuberkuloznih mikobakterijskih infekcija
|
|
US11033559B2
(en)
|
2015-09-29 |
2021-06-15 |
Osaka University |
Leukocyte infiltration promoting agent and antitumor immunostimulatory agent
|
|
CZ308596B6
(cs)
*
|
2017-04-03 |
2020-12-23 |
Ústav molekulární genetiky AV ČR, v. v. i. |
Deriváty fosfolipidů a jejich použití jako léčiva
|
|
WO2018204918A1
(en)
|
2017-05-05 |
2018-11-08 |
Ardelyx, Inc. |
Treatment of hepatic disorders
|
|
US11571386B2
(en)
|
2018-03-30 |
2023-02-07 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
EP3895709A1
(de)
|
2020-04-17 |
2021-10-20 |
Andreas Hettich GmbH & Co. KG |
Phospholipide und phospholipid-metaboliten zur behandlung von viralen und bakteriellen lungenentzündungen und sepsis
|